在慢性肝炎的治疗中,降酶治疗为一项较重要的治疗措施。近几年来,我院应用联苯双酯治疗慢性肝炎,经观察发现联苯双酯降酶疗效优于其他降酶剂。现报告如下。一、资料来源及治疗方法本组病例为我院干部病房及传染科病房1985～1987年所诊治的慢性活动性肝炎(以下简称慢活肝)住院病人,共100例。其中男70例,女30例;年龄最小20岁,最大为70 In the treatment of chronic hepatitis, reducing enzyme therapy is a more important treatment. In recent years, our hospital application of bifendate treatment of chronic hepatitis, observed by the observation that bifendate lower enzyme activity than other enzymes. The report is as follows. First, the sources and methods of treatment This group of patients for our hospital cadres and infectious wards 1985-1987 diagnosis and treatment of chronic active hepatitis (hereinafter referred to as slow living liver) inpatients, a total of 100 cases. Including 70 males and 30 females; the youngest 20 years old, up to 70